JIN MEDICAL INTERNATIONAL LTD. Empowers "Lao Le Hui" Assisted Bathing Project with Portable Nano-thermal Therapy Bath
2023年12月13日 - 10:30PM
JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ:
ZJYL), a Cayman Islands holding company with Chinese operating
entities that manufacture and develop wheelchairs and living aids
products, today announced the Company’s portable nano-thermal
therapy bath has been selected as the equipment for "Lao Le Hui"
Assisted Bathing Project (the “Project”). This significant
initiative is a collaborative effort between a recognized
foundation for the elderly in Shanghai, prominent state-owned
enterprises, and industry partners, with the noble purpose of
providing compassionate care and assistance to disabled or
semi-disabled elderly individuals residing in Shanghai. Over the
next two years, the Project aims to serve an impressive goal of
100,000 individuals and train 2,000 dedicated bathing attendants.
The Project aims to establish service centers
within communities, which ensures precise and targeted bathing
services for the elderly living in nearby residences. By fostering
a synergistic collaboration between local community health centers,
high-end nursing homes, dedicated volunteers, compassionate
individuals, and professional home care nursing staff, a
comprehensive and multifaceted framework can be established. This
framework encompasses promotional activities, personalized
recommendations, skills training and efficient coordination between
diverse personnel, resulting in a well-connected service system
centered around a holistic 15-minute healthy lifestyle circle for
the elderly population.
The Company’s role is to provide 1,000 sets of
nano-thermal therapy bath equipment and auxiliary medical devices
to help facilitate delivery of compassionate elderly care services
via this framework. Moreover, a transparent fee structure,
complemented by preferential settlements for public welfare causes,
will help grow the impact and awareness of this initiative. As the
Project progresses, the potential to further commercialize the
Company’s bath products is also amplified.
Mr. Wang Erqi, Chairman and CEO of the Company,
commented, “As a proud partner of the Project, we are fully
committed to supporting its widespread adoption and growth. By
providing state-of-the-art bathing equipment, we strive to enhance
service quality and work closely with our esteemed partners to
extend the benefits of this philanthropic endeavor to a larger
population of elderly individuals.”
“The launch of the Project is set to usher in an
era of enhanced care and warmth for disabled or semi-disabled
elderly individuals in Shanghai. Through our collective efforts, we
firmly believe that this commendable initiative will bring forth
improved health and increased happiness to a greater number of
elderly individuals in need.”
JinMed’s contribution in the form of the
portable nano-thermal therapy bath promises to elevate the bathing
experience while optimizing operational costs. Harnessing
cutting-edge nano-water particle thermal therapy technology, this
bath revolutionizes the traditional bathing paradigm by eliminating
the need for immersion in a conventional bathtub. Instead, it
offers a rejuvenating and comfortable experience within a
temperature range of 38-42°C, effectively mitigating the discomfort
associated with traditional saunas. Designed with the well-being of
individuals with weakened physical conditions and the elderly in
mind, this bath provides a unique opportunity for relaxation and
therapeutic bathing. The exceptional heat retention capability of
the nano-water particles ensures consistent warmth, while the
post-bathing humidifying effect replenishes the skin's moisture,
alleviating dryness-induced itching. Furthermore, the nano-water
particles and negative oxygen ions permeate the skin's pores,
facilitating an increase in both external and internal body
temperature. This process promotes the synthesis of heat shock
proteins, cellular activation, and heightened immune function.
About Jin Medical International
Ltd.
Founded in 2006 and headquartered at Changzhou
City, Jiangsu Province of China, the Company, through its Chinese
operating entities, designs and manufactures wheelchairs and living
aids products for people with disabilities, the elderly, and people
recovering from injuries. The Company’s Chinese operating entities
operate 2 manufacturing plants with approximately 228,257 square
feet in the aggregate in Changzhou City and Taizhou City, Jiangsu
Province, China. The Company’s Chinese operating entities have
established relationships with over 40 distributors in China, and
over 20 in the other regions of the world where it currently sells
the products. The majority of the Company’s wheelchair products,
with more than 30 models, are sold to dealers in Japan and China,
including Nissin Medical Industries Co., Ltd, one of the largest
medical device distributors in Japan. The Company’s Chinese
operating entities continuously deliver innovative wheelchair
designs that are both lightweight and ergonomic each year. For more
information, please visit: http://www.zhjmedical.com.
Forward-Looking Statement
This press release contains forward-looking
statements as defined by the Private Securities Litigation Reform
Act of 1995. Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events or
performances, and underlying assumptions and other statements that
are other than statements of historical facts. When the Company
uses words such as "may," "will," "intend," "should," "believe,"
"expect," "anticipate," "project," "estimate" or similar
expressions that do not relate solely to historical matters, it is
making forward-looking statements. Forward-looking statements are
not guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks, including, but not limited to, the
following: the Company's ability to achieve its goals and
strategies, the Company's future business development and plans for
future business development, including its financial conditions and
results of operations, product and service demand and acceptance,
reputation and brand, the impact of competition and pricing,
changes in technology, government regulations, fluctuations in
general economic and business conditions, and assumptions
underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the U.S. Securities
and Exchange Commission (“SEC”). For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, as
well as its current reports on Form 6-K and other filings, all of
which are available for review at www.sec.gov. The Company
undertakes no obligation to publicly revise these forward-looking
statements to reflect events or circumstances that arise after the
date hereof.
For more information, please
contact:ir@zhjmedical.com
Jin Medical (NASDAQ:ZJYL)
過去 株価チャート
から 10 2024 まで 11 2024
Jin Medical (NASDAQ:ZJYL)
過去 株価チャート
から 11 2023 まで 11 2024